Mehnert H
Int Z Vitam Ernahrungsforsch Beih. 1976;15:295-324.
The decreased glucsoe utilization in diabetes mellitus justifies the use of sugar substitutes ("diabetic sugar") if two conditions are fulfilled: 1)The sugar substitute should be a carbohydrate which does not lead, or only to a slight degree, to hyperglycaemia and thus, in this respect, differs distinctly from sugars such as glucose and saccharose. 2) The sugar substitute must not cause undesired side-effects. The absorption, utilization and side-effects of the sugar substitutes fructose, sorbitol and xylitol were investigated. They were found to be more slowly absorbed than glucose and thus to offer the advantage of better utilization under conditions of limited insulin production. However, the particularly slow passive absorption of sorbitol and xylitol can sometimes be a disadvantage, since osmotic diarrhoea may occur after administration of high oral doses. The sugar substitutes enter the metabolism enzymatically and are utilized mainly in the liver. The peripheral state was investigated after intravenous, intraduodenal and oral administration of glucose and fructose to healthy subjects. Liver metabolism was examined (Dietze) by comparing hepatic venous and arterial concentrations after intravenous administration of the sugars. Also, diabetic patients received glucose and fructose orally. As previously demonstrated, the investigations using several techniques showed a smaller influence on blood glucose and serum insulin concentrations after administration of fructose, sorbitol and xylitol than after glucose. If no metabolic changes occur after intravenous administration of high doses, no such changes need be expected after oral administration of small doses. Nor did measurements in hepatic venous blood (Dietze) show any marked effect of fructose on the blood glucose level. The healthy subjects showed no significant changes in blood glucose or serum insulin concentration after either intraduodenal or oral administration of fructose, whereas they showed a considerable increase after glucose administration. Investigations in adult-type diabetics revealed a better utilization of fructose than glucose. With correct dosage, sugar substitutes are able to increase the carbohydrate tolerance and, under certain conditions, to achieve a relative stabilization of the metabolism of unstable diabetics. The antiketogenic activity of sugar substitutes is particularly pronounced. Side-effects such as high blood levels of urea, lactate, triglycerides and bilirubin or a decrease in hepatic adenin nucleotides do not occur after oral administration, nor are they of importance after intravenous administration with correct dosage. The osmotic diarrhoea occurring after intake of sorbitol or xylitol is caused by their slow absorption and limits the consumption of these sugar substitutes. In the often obese adult-type diabetics, the calorie intake inherent in the consumption of diabetic sugars may have an unfavourable influence on their weight...
如果满足两个条件,糖尿病患者葡萄糖利用率降低就证明使用糖替代品(“糖尿病用糖”)是合理的:1)糖替代品应为碳水化合物,不会导致或仅轻微导致高血糖,因此在这方面与葡萄糖和蔗糖等糖类有明显区别。2)糖替代品不得引起不良副作用。对果糖、山梨醇和木糖醇等糖替代品的吸收、利用及副作用进行了研究。发现它们的吸收速度比葡萄糖慢,因此在胰岛素分泌受限的情况下具有更好利用的优势。然而,山梨醇和木糖醇特别缓慢的被动吸收有时可能是个缺点,因为口服高剂量后可能会出现渗透性腹泻。糖替代品通过酶促作用进入代谢过程,主要在肝脏中被利用。对健康受试者静脉注射、十二指肠内注射和口服葡萄糖及果糖后的外周状态进行了研究。通过比较静脉注射糖类后肝静脉和动脉的浓度来检查肝脏代谢(迪策)。此外,糖尿病患者口服葡萄糖和果糖。如先前所示,使用多种技术进行的研究表明,与葡萄糖相比,服用果糖、山梨醇和木糖醇后对血糖和血清胰岛素浓度的影响较小。如果静脉注射高剂量后未发生代谢变化,那么口服小剂量后也不应预期会有此类变化。肝静脉血测量(迪策)也未显示果糖对血糖水平有任何显著影响。健康受试者十二指肠内或口服果糖后血糖或血清胰岛素浓度无显著变化,而口服葡萄糖后则有相当大的升高。对成年型糖尿病患者的研究表明,果糖的利用率高于葡萄糖。正确用药时,糖替代品能够提高碳水化合物耐受性,在某些情况下还能使不稳定型糖尿病患者的代谢实现相对稳定。糖替代品的抗生酮活性尤为显著。口服后不会出现如血液中尿素、乳酸、甘油三酯和胆红素水平升高或肝腺嘌呤核苷酸减少等副作用,正确剂量静脉注射后也无此问题。摄入山梨醇或木糖醇后出现的渗透性腹泻是由其吸收缓慢引起的,这限制了这些糖替代品的使用。在通常肥胖的成年型糖尿病患者中,食用糖尿病用糖所固有的热量摄入可能会对他们的体重产生不利影响……